Taichung, Taiwan

Jia-Fong Ping

This inventor holds 1 USPTO granted patent. Top assignee: China Medical University. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jia-Fong Ping. Retrieved from https://idiyas.com/inventor/jia-fong-ping

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jia-Fong Ping

Introduction

Jia-Fong Ping is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of medical science, particularly in the treatment of viral infections. His innovative approach has garnered attention in the scientific community.

Latest Patents

Jia-Fong Ping holds a patent for a method of treating virus infections using a derivative of aniline. This method involves administering an effective amount of a derivative of aniline to a subject in need. The patent includes various forms of the compound, such as pharmaceutically acceptable salts and esters.

Career Highlights

Jia-Fong Ping is affiliated with China Medical University, where he continues to advance his research and development efforts. His work has the potential to impact the treatment of viral infections significantly.

Collaborations

Some of his notable coworkers include Cheng-Wen Lin and An-Cheng Huang, who contribute to his research endeavors.

Conclusion

Jia-Fong Ping's innovative work in treating viral infections showcases the importance of research and development in the medical field. His contributions are paving the way for new treatment methods that could benefit many.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…